JP2004529179A - 神経線維タンパク質のセグメントを使用する細胞死の予防法 - Google Patents

神経線維タンパク質のセグメントを使用する細胞死の予防法 Download PDF

Info

Publication number
JP2004529179A
JP2004529179A JP2002589032A JP2002589032A JP2004529179A JP 2004529179 A JP2004529179 A JP 2004529179A JP 2002589032 A JP2002589032 A JP 2002589032A JP 2002589032 A JP2002589032 A JP 2002589032A JP 2004529179 A JP2004529179 A JP 2004529179A
Authority
JP
Japan
Prior art keywords
ntp
segment
harlil
tissue
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2002589032A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529179A5 (enExample
Inventor
アヴァーバック，ポール・エイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nymox Corp
Original Assignee
Nymox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nymox Corp filed Critical Nymox Corp
Publication of JP2004529179A publication Critical patent/JP2004529179A/ja
Publication of JP2004529179A5 publication Critical patent/JP2004529179A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2002589032A 2001-05-16 2002-05-16 神経線維タンパク質のセグメントを使用する細胞死の予防法 Ceased JP2004529179A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29097101P 2001-05-16 2001-05-16
PCT/CA2002/000712 WO2002092115A2 (en) 2001-05-16 2002-05-16 Method of preventing cell death using segments of neural thread proteins

Publications (2)

Publication Number Publication Date
JP2004529179A true JP2004529179A (ja) 2004-09-24
JP2004529179A5 JP2004529179A5 (enExample) 2006-01-05

Family

ID=23118262

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002589032A Ceased JP2004529179A (ja) 2001-05-16 2002-05-16 神経線維タンパク質のセグメントを使用する細胞死の予防法

Country Status (12)

Country Link
US (1) US7572450B2 (enExample)
EP (1) EP1392347B1 (enExample)
JP (1) JP2004529179A (enExample)
KR (1) KR20040008177A (enExample)
CN (1) CN1558770A (enExample)
AT (2) ATE381342T1 (enExample)
BR (1) BR0209630A (enExample)
CA (1) CA2446945A1 (enExample)
DE (2) DE60205366T2 (enExample)
DK (1) DK1392347T3 (enExample)
ES (1) ES2247329T3 (enExample)
WO (1) WO2002092115A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259232B1 (en) * 2000-10-27 2007-08-21 Nymox Pharmaceutical Corporation Preferred segments of neural thread protein
BR0209990A (pt) * 2001-05-25 2004-06-29 Nymox Corp Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
US7317077B2 (en) * 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
US7544771B2 (en) * 2005-02-23 2009-06-09 Nymox Corporation Protein and its use in diagnosing Alzheimer's disease
US20160361380A1 (en) * 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378924B1 (en) * 1988-12-21 1996-11-13 The General Hospital Corporation Detection of neurological disease or dysfunction
US5948634A (en) * 1988-12-21 1999-09-07 The General Hospital Coporation Neural thread protein gene expression and detection of alzheimer's disease
KR100392244B1 (ko) 1993-04-20 2003-11-28 더 제너럴 호스피탈 코포레이션 신경사단백질유전자발현및알쯔하이머병의검출
CN1300778A (zh) * 1999-12-22 2001-06-27 上海博德基因开发有限公司 一种新的多肽－人神经元线蛋白15和编码这种多肽的多核苷酸
CN1300779A (zh) 1999-12-22 2001-06-27 上海博德基因开发有限公司 一种新的多肽－人神经元线蛋白17和编码这种多肽的多核苷酸
US7259232B1 (en) * 2000-10-27 2007-08-21 Nymox Pharmaceutical Corporation Preferred segments of neural thread protein
DE60222745T2 (de) * 2001-03-08 2008-07-10 Nymox Pharmaceutical Corp., St. Laurent Verwendung von neurofilamentproteinen zur behandlung von tumoren

Also Published As

Publication number Publication date
DE60205366D1 (de) 2005-09-08
DE60205366T2 (de) 2006-05-24
DK1392347T3 (da) 2005-12-12
KR20040008177A (ko) 2004-01-28
BR0209630A (pt) 2004-03-30
ES2247329T3 (es) 2006-03-01
US20030004107A1 (en) 2003-01-02
CN1558770A (zh) 2004-12-29
CA2446945A1 (en) 2002-11-21
WO2002092115A3 (en) 2003-05-15
ATE381342T1 (de) 2008-01-15
ATE300951T1 (de) 2005-08-15
DE60224231D1 (de) 2008-01-31
EP1392347B1 (en) 2005-08-03
WO2002092115A2 (en) 2002-11-21
HK1060851A1 (en) 2004-08-27
US7572450B2 (en) 2009-08-11
EP1392347A2 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
CN107921085B (zh) 用于治疗衰老相关病症的方法和组合物
US9149444B2 (en) Modulation of synaptic maintenance
CN101534648B (zh) 使用mntf肽及其类似物治疗神经紊乱的方法
US7572450B2 (en) Composition for preventing cell death and/or tissue necrosis resulting from contact with neural thread proteins
JP2005535565A (ja) アルツハイマー病の症状を治療することが可能な化合物を決定する際に有用なスフェロン構成要素、並びに該構成要素から産生される治療および動物モデル
US7514407B2 (en) Spheron component peptides and pharmaceutical compositions
EP1541166B1 (en) Preventing cell death using segments of neural thread proteins
AU2002302239B2 (en) Method of preventing cell death using segments of neural thread proteins
EP1387698B1 (en) Method of preventing cell death using antibodies to neural thread proteins
AU2002302239A1 (en) Method of preventing cell death using segments of neural thread proteins
HK1060851B (en) Preventing cell death using segments of neural thread proteins
AU2002308327A1 (en) Method of preventing cell death using antibodies to neural thread proteins

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050513

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050513

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080812

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081112

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20081224

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20090423